DCP
ELV icon

Distillate Capital Partners’s Elevance Health ELV Stock Holding History

Distillate Capital Partners’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-76,502
Closed -$24.7M – 121
2025
Q3 		$24.7M Buy
76,502
+18,508
+32% +$5.76M 1.28% 19
2025
Q2 		$22.6M Sell
57,994
-4,653
-7% -$1.87M 1.21% 22
2025
Q1 		$27.2M Sell
62,647
-17,314
-22% -$6.95M 1.4% 11
2024
Q4 		$29.5M Sell
79,961
-41,241
-34% -$17.3M 1.45% 11
2024
Q3 		$63M Buy
121,202
+67,195
+124% +$35.9M 3.16% 5
2024
Q2 		$29.3M Buy
54,007
+53,980
+199,926% +$28.5M 1.55% 11
2024
Q1 		$14K Hold
27
– – 2.35% 24
2023
Q4 		$12.7K Hold
27
– – 2.77% 22
2023
Q3 		$11.8K Buy
27
+4
+17% +$1.81K 2.97% 30
2023
Q2 		$10.2K Buy
+23
New +$10.6K 3.31% 21
2022
Q4 		– Sell
-19,077
Closed -$8.64M – 119
2022
Q3 		$8.64M Sell
19,077
-2,535
-12% -$1.21M 1.16% 17
2022
Q2 		$10.4M Buy
21,612
+2,237
+12% +$1.11M 1.49% 14
2022
Q1 		$9.52M Buy
19,375
+1,444
+8% +$660K 1.35% 16
2021
Q4 		$8.31M Buy
17,931
+5,470
+44% +$2.3M 1.39% 15
2021
Q3 		$4.64M Buy
+12,461
New +$4.74M 1.24% 18
2021
Q2 		– Sell
-11,017
Closed -$3.96M – 124
2021
Q1 		$3.96M Buy
11,017
+2,024
+23% +$651K 1.28% 15
2020
Q4 		$2.82M Buy
+8,993
New +$2.76M 1.35% 12

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Distillate Capital Partners's ELV Position: Q4 2025 in Review

Distillate Capital Partners sold out of Elevance Health (ELV) in Q4 2025, closing a stake of 76,502 shares — an estimated $24.7M sold.

Distillate Capital Partners first reported a position in ELV in Q4 2020 and held it in 17 quarters. The position peaked at $63M in Q3 2024. 1,553 funds tracked by Wall St. Rank hold ELV as of Q4 2025.

  • Distillate Capital Partners reported no remaining Elevance Health position as of Q4 2025 after selling out during the quarter.
  • Distillate Capital Partners sold 76,502 Elevance Health shares in Q4 2025, an estimated $24.7M.
  • Distillate Capital Partners first reported a position in Elevance Health in Q4 2020 and held it in 17 quarters.
  • Distillate Capital Partners's Elevance Health position peaked at $63M in Q3 2024.
  • 1,553 funds tracked by Wall St. Rank held Elevance Health as of Q4 2025.

Based on Distillate Capital Partners's 13F filing for Q4 2025, filed 12 Feb 2026.